FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

764296002: Prolonged-release subcutaneous implant (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3647392011 Prolonged-release subcutaneous implant en Synonym Active Entire term case insensitive SNOMED CT core module
3647393018 Prolonged-release subcutaneous implant (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release subcutaneous implant Has dose form administration method Insert false Inferred relationship Existential restriction modifier
Prolonged-release subcutaneous implant Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Prolonged-release subcutaneous implant Has dose form intended site Subcutaneous true Inferred relationship Existential restriction modifier
Prolonged-release subcutaneous implant Has dose form release characteristic Prolonged-release true Inferred relationship Existential restriction modifier
Prolonged-release subcutaneous implant Has basic dose form Implant true Inferred relationship Existential restriction modifier
Prolonged-release subcutaneous implant Is a Subcutaneous dose form true Inferred relationship Existential restriction modifier
Prolonged-release subcutaneous implant Has dose form administration method Implant true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely estradiol 50 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely estradiol 100 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Etonogestrel 68mg subdermal implant Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely goserelin (as goserelin acetate) 3.6 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely testosterone 100 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely testosterone 200 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely levonorgestrel 75 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form True Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely etonogestrel 68 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form True Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely goserelin (as goserelin acetate) 3.6 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely estradiol 50 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely estradiol 100 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely testosterone 100 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely testosterone 200 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Etonogestrel 68mg subdermal implant Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely goserelin (as goserelin acetate) 3.6 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form True Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form True Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely goserelin (as goserelin acetate) 3.6 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely estradiol 50 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely testosterone 100 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely estradiol 100 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely testosterone 200 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Etonogestrel 68mg subdermal implant Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely goserelin (as goserelin acetate) 3.6 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely testosterone 200 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely estradiol 50 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely testosterone 100 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Product containing precisely estradiol 100 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Etonogestrel 68mg subdermal implant Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Zoladex 3.6mg implant SafeSystem pre-filled syringes (Pharmaram Ltd) Has manufactured dose form True Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Zoladex 3.6mg implant SafeSystem pre-filled syringes (Originalis B.V.) Has manufactured dose form True Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier
Zoladex LA 10.8mg implant SafeSystem pre-filled syringes (Originalis B.V.) Has manufactured dose form True Prolonged-release subcutaneous implant Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start